GT Biopharma, Inc.

GTBP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
EFFECT Oct 20, 2026
424B3 Oct 20, 2026 424B3
DEF 14A Oct 13, 2026 DEF 14A
S-1 Oct 9, 2026 S-1
PRE 14A Oct 2, 2026 PRE 14A
D Sep 29, 2026
8-K Sep 25, 2026 8-K
8-K Sep 21, 2026 8-K
SCHEDULE 13G Sep 15, 2026
8-K Sep 15, 2026 8-K
8-K Sep 3, 2026 8-K
8-K Aug 14, 2026 8-K
10-Q Aug 14, 2026 10-Q
DEF 14A Jul 2, 2026 DEF 14A
PRE 14A Jun 18, 2026 PRE 14A
8-K Jun 12, 2026 8-K
8-K May 22, 2026 8-K
10-Q May 15, 2026 10-Q
EFFECT May 13, 2026
424B3 May 13, 2026 424B3
CORRESP May 11, 2026
UPLOAD May 6, 2026
S-1 Apr 30, 2026 S-1
8-K Apr 7, 2026 8-K
10-Q/A Mar 6, 2026 10-Q/A
← Newer Page 1 of 33 · 811 filings Older →